Table 1.
Overall N = 102 |
CMV and BKPyV N = 9 |
CMV Only N = 28 |
BKPyV Only N = 9 |
No Infection N = 56 |
|
---|---|---|---|---|---|
Age, mean (SD) | 63 (9) | 59 (7) | 63 (9) | 67 (7) | 63 (10) |
Race/ethnicity, n (%) | |||||
African American | 67 (65.7) | 5 (55.6) | 22 (78.6) | 3 (33.3) | 37 (66.1) |
White | 27 (26.5) | 1 (11.1) | 6 (21.4) | 5 (55.6) | 15 (26.8) |
Hispanic | 4 (3.9) | 2 (22.2) | 0 (0.0) | 0 (0.0) | 2 (3.6) |
Other | 4 (3.9) | 1 (11.1) | 0 (0.0) | 1 (11.1) | 2 (3.6) |
Cause of ESRD, n (%) | |||||
Hypertension | 26 (25.5) | 0 (0.0) | 13 (46.4) | 2 (22.2) | 11 (19.6) |
Diabetes | 46 (45.1) | 7 (77.8) | 11 (39.3) | 3 (33.3) | 25 (44.6) |
Other | 30 (29.4) | 2 (22.2) | 4 (14.3) | 4 (44.4) | 20 (35.7) |
Transplant type, n (%) | |||||
DCD | 28 (27.5) | 5 (55.6) | 8 (28.6) | 1 (11.1) | 14 (25.0) |
DDKT | 71 (69.6) | 4 (44.4) | 18 (64.3) | 8 (88.9) | 41 (73.2) |
LRKT | 2 (2.0) | 0 (0.0) | 1 (3.6) | 0 (0.0) | 1 (1.8) |
LUKT | 1 (1.0) | 0 (0.0) | 1 (3.6) | 0 (0.0) | 0 (0.0) |
History of hepatitis C, n (%) | 29 (28.4) | 3 (33.3) | 8 (28.6) | 4 (44.4) | 14 (25.0) |
History of hepatitis B, n (%) | 9 (8.8) | 0 (0.0) | 3 (10.7) | 1 (11.1) | 5 (8.9) |
Immunologic risk, n (%) | 10 (9.8) | 2 (22.2) | 1 (3.6) | 3 (33.3) | 4 (7.1) |
CMV risk, n (%) | |||||
1 | 6 (5.9) | 0 (0.0) | 0 (0.0) | 1 (11.1) | 5 (8.9) |
2 | 48 (47.1) | 5 (55.6) | 12 (42.9) | 4 (44.4) | 27 (48.2) |
3 | 48 (47.1) | 4 (44.4) | 16 (57.1) | 4 (44.4) | 24 (42.9) |
cPRA > 0, n (%) | 8 (7.8) | 3 (33.3) | 1 (3.6) | 1 (11.1) | 3 (5.4) |
Donor age, mean (SD) | 42 (13) | 42 (11) | 44 (12) | 39 (14) | 42 (13) |
KDPI, median (IQR) | 53 (41–75) | 57 (49–80) | 60 (42–84) | 43 (42–67) | 51 (35–68) |
Induction, n (%) | |||||
<4 mg/kg | 31 (30.4) | 4 (44.4) | 9 (32.1) | 1 (11.1) | 17 (30.4) |
>4 mg/kg | 38 (37.3) | 4 (44.4) | 13 (46.4) | 3 (33.3) | 18 (32.1) |
Basiliximab | 33 (32.4) | 1 (11.1) | 6 (21.4) | 5 (55.6) | 21 (37.5) |
Delayed graft function, n (%) | 31 (30.4) | 4 (44.4) | 5 (17.9) | 3 (33.3) | 19 (33.9) |
Death, n (%) | 2 (2.0) | 0 (0.0) | 1 (3.6) | 0 (0.0) | 1 (1.8) |
SD—standard deviation; IQR—interquartile range; ESRD—end stage kidney disease; cPRA—Calculated Panel Reactive Antibody; KDPI—Kidney Donor Profile Index; DCD—donation after circulatory death; DDKT—deceased donor kidney transplantation; LRKT—living related kidney transplantation; LUKT—living unrelated kidney transplantation.